Bayer launches pill to treat chronic kidney disease linked to diabetes

The drug, touted as a potential blockbuster drug for the German pharmaceutical firm, will be sold under the brand name Kerendia in India.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/5os4xhB
via IFTTT